HTN is defined as a persistent elevation of office blood pressure (BP) ≥ 140/90 mmHg. Measured on three separate occasions within four weeks (2011 Guidelines state 8 weeks), unless the BP is ≥ 180/110. The blood pressure should also be recorded in the correct manner. The optimal BP is a value < 130/85 mmHg. Patients with BP ≥ 160/110mmHg should begin drug therapy and lifestyle modification. Patients with Grade 1 hypertension should begin with lifestyle modification for three to six months unless they are stratified as being “high risk”. High-risk patients are those with three or more major risk factors, diabetes, target-organ damage, or complications of hypertension (see table below).
| Stage | Systolic BP mmHg | Diastolic BP mmHg |
|---|---|---|
| Normal | < 120 | <80 |
| Optimal | 120 – 129 | 80 – 84 |
| High Normal | 130 – 139 | 85 – 89 |
| Grade 1 | 140 – 159 | 90 – 99 |
| Grade 2 | 160 – 179 | 100 – 109 |
| Grade 3 | ≥ 180 | ≥ 110 |
| Isolated systolic | ≥ 140 | < 90 |
The blood pressure measurement should also be measured correctly. There are a few things one should keep in mind while performing the blood pressure reading. The table below describes some of the most common, but there are more!
| Recommendation for BP Measurement |
|---|
|
- Patient sits for 3-5mins before BP measurement - SBP is measured by palpation first, in order to avoid missing the auscultatory gap - Take two readings, 2 minutes apart. If the next reading is more than 5mmHg different from the previous one then repeat. - Measure both arms’ BP - Patient should be seated, with arm supported at heart level - Patient should have NOT smoked, taken caffeine in the previous 30minutes - The correct cuff size - Take Korotkoff I and V as SBP and DBP |
You need to assess the following three things (major risk factors, target organ damage, and complications) for each patient. These findings will help you identify the patients that are “high risk” patients, and these patients will also need treatment.
| Major Risk Factors | Target Organ Damage (TOD) | Complications |
|---|---|---|
|
-level of systolic and diastolic BP -smoking -dyslipidemia (Total Cholesterol > 5.1 mmol/L OR LDL > 3mmol/L OR HDL in MEN < 1 and WOMEN < 1.2mmol/L -Diabetes Mellitus -Men age > 55 -Women age > 65 -Family history of early onset cardiovascular disease (Men Aged < 55, Women Aged < 65) -Waist Circumference (Men ≥ 102cm, Women ≥ 88cm). However South Asians and Chinese waist circumference in men > 90cm and in women > 80cm |
-Left Ventricular Hypertrophy (based on ECG as Sokolow-Lyons > 35mm, R in aVL > 11mm, Cornel > 2440 mm/ms) -MICROalbuminuria (Albumin:Creatinine ratio of 3 – 30mg/mmol from spot urine in the mornings and an eGFR > 60ml/min) |
-Stroke/TIA -Advanced Retinopathy (hemorrhages, exudates OR papilledema) -Coronary Heart Disease -Heart Failure -Chronic Kidney Disease (MACROalbuminuria > 30mg/mmol OR eGFR < 60ml/min) |
NB: You can start with either of the medications described below, but always consider the patient profile, agent/drug profile, and/or any indications.
Notes: Loop diuretics such as furosemide should not be used because of their short duration of hypotensive activity (about 6 hours), unless there is evidence of chronic kidney disease (CKD) with an estimated glomerular filtration rate (GFR) <45 ml/min.
The triangle below shows how you can initiate the patient’s treatment. You may select either an ACEI/ARB OR Thiazide OR a CCB. You will then need to remember some common side effects.
For instance, you initiate the patient on a Thiazide, then you realize on a review that the treatment is not working. You can pick either an ACEI/ARB or CCB.
If the treatment is still not successful, then you can select the remaining agent in the triangle. Then you can consider optimizing the agent’s doses (by increasing the dose).
If there is still an issue with the patient’s blood pressure, then you may consider adding a 4th agent. Before jumping to a B-Blocker (Carvedilol), you may consider using an MRA(Spironolactone).
You need to select an agent that will benefit the patient. For instance, patients with Diabetes Mellitus benefit from ACE Inhibitors. B-Blockers are contra-indicated in patients with Diabetes. Although it is stated that some agents have “poor response in Africans”, it does not mean that they should not be used. It just means that these agents should ideally not be used alone or as first-line treatment.
For more information, read our article called, “Common drugs used for hypertension.“
Disclaimer: The information written above is mostly adapted from the South African Hypertension Practice Guidelines 2014 (YK Seedat, BL Rayner, Yosuf Veriava) and full credit is given to their authors. Where possible, information from the South African Hypertension Guidelines 2011 (Y K Seedat, B L Rayner) was also used and from the EML Guidelines.

Follow this link in order to download the latest Hypertension Guidelines.
Made with ❤️ by QuickBeat
We are a small education agency that aims to provide medical education.